ArrowMark Colorado Holdings’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.38M | Sell |
3,188,116
-120,561
| -4% | -$128K | 0.06% | 208 |
|
|
2025
Q1 | $3.61M | Sell |
3,308,677
-199,774
| -6% | -$218K | 0.06% | 200 |
|
|
2024
Q4 | $5.3M | Sell |
3,508,451
-138,840
| -4% | -$210K | 0.07% | 188 |
|
|
2024
Q3 | $5.43M | Buy |
3,647,291
+842,509
| +30% | +$1.26M | 0.07% | 184 |
|
|
2024
Q2 | $4.54M | Sell |
2,804,782
-393,974
| -12% | -$638K | 0.05% | 209 |
|
|
2024
Q1 | $5.44M | Buy |
3,198,756
+484,613
| +18% | +$824K | 0.06% | 207 |
|
|
2023
Q4 | $8.41M | Buy |
2,714,143
+2,443,717
| +904% | +$7.58M | 0.09% | 159 |
|
|
2023
Q3 | $1.66M | Hold |
270,426
| – | – | 0.02% | 243 |
|
|
2023
Q2 | $1.69M | Sell |
270,426
-629,135
| -70% | -$3.94M | 0.02% | 234 |
|
|
2023
Q1 | $4.29M | Sell |
899,561
-65,424
| -7% | -$312K | 0.05% | 205 |
|
|
2022
Q4 | $8.4M | Buy |
964,985
+85,523
| +10% | +$744K | 0.1% | 173 |
|
|
2022
Q3 | $10.5M | Buy |
879,462
+47,996
| +6% | +$571K | 0.13% | 144 |
|
|
2022
Q2 | $11.8M | Buy |
831,466
+263,117
| +46% | +$3.75M | 0.14% | 143 |
|
|
2022
Q1 | $11.8M | Buy |
568,349
+25,044
| +5% | +$521K | 0.1% | 165 |
|
|
2021
Q4 | $12.6M | Buy |
543,305
+15,885
| +3% | +$367K | 0.1% | 170 |
|
|
2021
Q3 | $15.7M | Buy |
527,420
+94,292
| +22% | +$2.81M | 0.12% | 145 |
|
|
2021
Q2 | $14.8M | Buy |
433,128
+38,065
| +10% | +$1.3M | 0.11% | 156 |
|
|
2021
Q1 | $13M | Buy |
395,063
+2,455
| +0.6% | +$80.7K | 0.1% | 165 |
|
|
2020
Q4 | $24.1M | Sell |
392,608
-7,392
| -2% | -$455K | 0.19% | 113 |
|
|
2020
Q3 | $14.2M | Buy |
+400,000
| New | +$14.2M | 0.14% | 123 |
|